Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: Report of six cases

Table 3 The treatment and prognosis of six graft-versus-host disease patients

Patients	Methylprednisolone	Immunosuppressant					IVIG	CRRT	G-CSF/GM-CSF
		Tacrolimus	Cyclosporin	Basiliximab/Zenapax	TNF-α inhibitor	ATG
Case 1	10 mg/kg/d	+	-	Zenapax (2 doses)	-	-	+	-	+
Case 2	10 mg/kg/d	-	↓	-	-	-	+	-	+
Case 3	8 mg/kg/d	-	↓	-	-	50 mg/d, 2 d	+	-	+
Case 4	10 mg/kg/d	↓	-	-	Infliximab, 300 mg/d, 1 d	-	+	+	+
Case 5	7 mg/kg/d	+	-	-	-	-	+	-	+
Case 6	8 mg/kg/d	+	-	Basiliximab (2 doses)	-	-	+	-	+

TNF-α: Tumor necrosis factor-alpha; IVIG: Human normal immunoglobulin; CRRT: Continuous renal replacement therapy; G-CSF: Granulocyte colony-stimulating factor; GM-CSF: Granulocyte-macrophage colony-stimulating factor.